Replies to post #611109 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

Submission in 2023 is clearly the guidance. This is the same misleading bullshit pushed by our paid posting friends.

[Foogie88]

Well what are they going to do for $$$ that long? Already using a toxic financier and I think those notes are going due in November of 23. What? Are they going to do a Secondary at .56? How bout bringing on a Partner. I see no other way if the timeline is that long.

[churchill_21]

Lack of hiring is very telling (especially with plans for 4 markets). Also, he was fairly open in that interview, so I would think if they were going to submit this year, he would have said we are hoping or planning to submit this year. Most companies announce when they plan to submit, typically upon data readout, they will give a general timeline of submission. Example from a PR yesterday where the company gives data results and a timeline for FDA. https://investor.bridgebio.com/news-releases/news-release-details/bridgebio-announces-consistently-positive-results-phase-3